<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Solianis Monitoring AG</title>
	<atom:link href="http://blog.taragana.com/pr/t/solianis-monitoring-ag/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.taragana.com/pr</link>
	<description></description>
	<pubDate>Thu, 01 Apr 2010 05:00:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Solianis Monitoring AG Participates in the Pioneering EU-Project REACTION for Improved Diabetes Management</title>
		<link>http://blog.taragana.com/pr/solianis-monitoring-ag-participates-in-the-pioneering-eu-project-reaction-for-improved-diabetes-management-15506/</link>
		<comments>http://blog.taragana.com/pr/solianis-monitoring-ag-participates-in-the-pioneering-eu-project-reaction-for-improved-diabetes-management-15506/#comments</comments>
		<pubDate>Thu, 01 Apr 2010 05:00:00 +0000</pubDate>
		<dc:creator>Solianis Monitoring Ag</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[April 1]]></category>

		<category><![CDATA[Solianis Monitoring AG]]></category>

		<category><![CDATA[Switzerland]]></category>

		<category><![CDATA[Zurich]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/solianis-monitoring-ag-participates-in-the-pioneering-eu-project-reaction-for-improved-diabetes-management-15506/</guid>
		<description><![CDATA[ZURICH, April 1, 2010  - Solianis Monitoring AG is an important project partner in the
development of REACTION, a professional service platform for doctors,
caregivers and patients to improve the long term management of diabetes.

    The objective of the project is to improve glucose control in
insulin requiring patients with diabetes by combining continuous [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/solianis-monitoring-ag-participates-in-the-pioneering-eu-project-reaction-for-improved-diabetes-management-15506/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Solianis Monitoring AG on its Way to Success - Market Entry as Planned in 2011</title>
		<link>http://blog.taragana.com/pr/solianis-monitoring-ag-on-its-way-to-success-market-entry-as-planned-in-2011-12772/</link>
		<comments>http://blog.taragana.com/pr/solianis-monitoring-ag-on-its-way-to-success-market-entry-as-planned-in-2011-12772/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 05:00:00 +0000</pubDate>
		<dc:creator>Solianis Monitoring Ag</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Solianis Monitoring AG]]></category>

		<category><![CDATA[Switzerland]]></category>

		<category><![CDATA[Zurich]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/solianis-monitoring-ag-on-its-way-to-success-market-entry-as-planned-in-2011-12772/</guid>
		<description><![CDATA[ZURICH, February 8  - Solianis Monitoring AG presents its Non-Invasive, Continuous
Glucose Monitoring System at the 3rd International Conference on Advanced
Technologies and Treatments for Diabetes (Basel, Switzerland, February 10-13,
2010).

    Dr. Andreas Caduff, PhD, Chief Technology Officer of Solianis,
will present the concept of Solianis&#39; proprietary Multisensor Glucose
Monitoring System (MGMS) which in first tests [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/solianis-monitoring-ag-on-its-way-to-success-market-entry-as-planned-in-2011-12772/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Long-term Investment Secured - Swiss Foundation Supports Innovative Concept for Patients With Diabetes</title>
		<link>http://blog.taragana.com/pr/long-term-investment-secured-swiss-foundation-supports-innovative-concept-for-patients-with-diabetes-3800/</link>
		<comments>http://blog.taragana.com/pr/long-term-investment-secured-swiss-foundation-supports-innovative-concept-for-patients-with-diabetes-3800/#comments</comments>
		<pubDate>Fri, 03 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Financing Agreements]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Solianis Monitoring AG]]></category>

		<category><![CDATA[Western Europe]]></category>

		<category><![CDATA[Zurich]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/long-term-investment-secured-swiss-foundation-supports-innovative-concept-for-patients-with-diabetes-3800/</guid>
		<description><![CDATA[ZÜRICH - Solianis recently signed an investment agreement with a Swiss foundation which invests its assets in Swiss companies. According to the agreement, this foundation will put CHF 5 million, while the previous investors in Solianis are investing another CHF 3 million.

&#8220;The CHF 8 million invested will enable us to increase our efforts to complete [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/long-term-investment-secured-swiss-foundation-supports-innovative-concept-for-patients-with-diabetes-3800/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

